Evaluation of 2-year outcomes following intravitreal bevacizumab (IVB) for aggressive posterior retinopathy of prematurity

Creative Commons License

Gunay M., ÇELİK G., Gunay B. O., AKTAŞ A., KARATEKİN G., Ovali F.

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, vol.78, no.5, pp.300-304, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 78 Issue: 5
  • Publication Date: 2015
  • Doi Number: 10.5935/0004-2749.20150079
  • Journal Name: ARQUIVOS BRASILEIROS DE OFTALMOLOGIA
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.300-304
  • Keywords: Bevacizumab, Intravitreal injections, Laser therapy, Retinopathy of prematurity, Treatment outcomes, ENDOTHELIAL GROWTH-FACTOR, THRESHOLD RETINOPATHY, LASER PHOTOCOAGULATION, PRETHRESHOLD RETINOPATHY, RETINAL-DETACHMENT, REFRACTIVE ERROR, CRYOTHERAPY, INFANTS, MONOTHERAPY, TRIAL
  • Karadeniz Technical University Affiliated: No

Abstract

Purpose: To evaluate 2-year outcomes following intravitreal bevacizumab (IVB) as monotherapy for aggressive posterior retinopathy of prematurity (APROP).